Atom is covered by 36Kr, a China-based publishing and data company focused on the “new economy” Beijing in an article (https://www.36kr.com/p/1664114593650441).
“Atom Semiconductor (AtomSemi), a high-performance analog chip company, received nearly 100 million RMB in its Pre-A round funding. This round of funding was led by Qiming Venture Partners and joined by listed company Venus Medtech and shareholder Alibaba Entrepreneurs Fund.
The technical advantages of Atom Semiconductor are mainly reflected in its ability to enable its chip products to achieve a high integration level while attaining high performance simultaneously, as well as being able to be applied its chip products to a wider range of application scenarios. AtomSemi has found out that, in the recent years, customers of consumer electronics hope to realize more functions while using as few chips as possible. Therefore, based on the above, AtomSemi is seeking a breakthrough – Design a single chip that can perform tasks which normally requires three separate chips. AS1412 is a highly integrated 24-bit Sigma-Delta ADC chip. It is highly precise and with a power consumption three times lower than similar products, making it suitable for use in portable consumer electronic sensor products, such as temperature sensors, pressure sensors, etc.
The advantages of AtomSemi are related to its team of talents and technical reserves. Founder Jie Yuan is the Associate Head of the Department of Electronic and Computer Engineering of The Hong Kong University of Science and Technology. He has accumulated more than 20 years of experience in the field of semiconductor technology and has developed 20+ high performance analog chips. AtomSemi’s founding team comprises of talents originating from well-known chip companies such as Marvell, Texas Instruments, AMD, and Tektronix, as well as top universities such as Harvard University, University of Pennsylvania, The Hong Kong University of Science and Technology, and Tsinghua University. Among the employees (30+) in the company, 75% of them are R&D personnel.”